NCT03483077View on ClinicalTrials.gov

This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood.

PHASE1TerminatedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 9, 2018

Primary Completion Date

March 21, 2019

Study Completion Date

March 21, 2019

Conditions
Healthy
Interventions
DRUG

BI 730460

tablets

DRUG

Placebo

tablets

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03483077 - This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood. | Biotech Hunter | Biotech Hunter